Type I interferon production induced by Streptococcus pyogenes-derived nucleic acids is required for host protection

The STING in the tail for cytosolic DNA-dependent activation of IRF3

Cytosolic pattern recognition receptors (PRRs) sense intracellular nucleic acids from pathogens such as bacteria and viruses, which leads to the induction of type I interferon (IFN) responses that are essential for an effective immune response. Further, these PRR pathways can be aberrantly activated by self DNA, which leads to autoimmunity. Therefore, understanding the signaling mechanisms that underlie PRR-induced production of IFN is vital to health and disease. A key transcription factor that is involved in these pathways is IFN regulatory factor 3 (IRF3), which is often activated by the kinase TANK-binding kinase 1 (TBK1). STING (stimulator of interferon genes) is a master regulator for the cyto-solic nucleic acid-mediated activation of IRF3 through TBK1 stimulation, but how the STING-TBK1-IRF3 signaling axis operates has been unclear. A study now shows that in response to cytosolic double-stranded DNA, the C-terminal tail of STING provides a scaffold to assemble IRF3 and TBK1, which leads to TBK1-dependent phosphorylation of IRF3. Thus, STING directs TBK1 to activate IRF3 in DNA-sensing pathways.

Type I interferons: diversity of sources, production pathways and effects on immune responses

Type I interferons (IFN-I) were first described over 50 years ago as factors produced by cells that interfere with virus replication and promote an antiviral state. Innate and adaptive immune responses to viruses are also greatly influenced by IFN-I. In this article we discuss the diversity of cellular sources of IFN-I and the pathways leading to IFN-I production during viral infections. Finally, we discuss the effects of IFN-I on cells of the immune system with emphasis on dendritic cells.

Type I interferon response to extracellular bacteria in the airway epithelium

The airway epithelium possesses many mechanisms to prevent bacterial infection. Not only does it provide a physical barrier, but it also acts as an extension of the immune system through the expression of innate immune receptors and corresponding effectors. One outcome of innate signaling by the epithelium is the production of type I interferons (IFNs), which have traditionally been associated with activation via viral and intracellular organisms. We discuss how three extracellular bacterial pathogens of the airway activate this intracellular signaling cascade through both surface components as well as via secretion systems, and the differing effects of type I IFN signaling on host defense of the respiratory tract.